Clusters of Multiple Mutations: Incidence and Molecular Mechanisms

Annual Review of Genetics

Volumn 49, Issue , 2015, Pages 243-267

  Chan, Kin ^a   Gordenin, Dmitry A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cancer; Evolution; Genome instability; Kataegis; Mutagenesis; Mutation showers

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CYTIDINE DEAMINASE; DOUBLE STRANDED DNA; SINGLE STRANDED DNA; DNA; RETROPOSON;

ARTICLE; ASCOMYCETES; CANCER GENETICS; CHROMOSOME; DNA DAMAGE; GENE CLUSTER; GENE MUTATION; GENETIC VARIABILITY; GERMLINE MUTATION; HUMAN; IMMUNOGLOBULIN GENE; MEIOSIS; MOLECULAR GENETICS; MUTAGENESIS; MUTATION RATE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RETROVIRIDAE; SOMATIC HYPERMUTATION; TELOMERE; TUMOR GENE; YEAST CELL; ANIMAL; CYTOLOGY; DNA REPAIR; GENETICS; MUTANT MOUSE STRAIN; MUTATION; MUTATION ACCUMULATION; NEOPLASM; PHYSIOLOGY; RETROPOSON; YEAST;

ANIMALS; DNA; DNA REPAIR; DNA, SINGLE-STRANDED; HUMANS; MICE, MUTANT STRAINS; MUTAGENESIS; MUTATION; MUTATION ACCUMULATION; NEOPLASMS; RETROELEMENTS; TELOMERE; YEASTS;

EID: 84948731931     PISSN: 00664197     EISSN: 15452948     Source Type: Book Series    
DOI: 10.1146/annurev-genet-112414-054714     Document Type: Article

References (143)

1. Aguilera A, Garcia-Muse T. 2012. R loops: from transcription byproducts to threats to genome stability. Mol. Cell 46:115-24
2. Albin JS, Hache G, Hultquist JF, Brown WL, Harris RS. 2010. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function. J. Virol. 84:10209-19
3. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, et al. 2013. Signatures of mutational processes in human cancer. Nature 500:415-21
4. Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, StrattonMR. 2013. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3:246-59
5. Alexandrov LB, Stratton MR. 2014. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr. Opin. Genet. Dev. 24:52-60
6. Anwar F,DavenportMP, EbrahimiD. 2013. Footprint of APOBEC3 on the genome of human retroelements. J. Virol. 87:8195-204
7. Aramayo R, Selker EU. 2013. Neurospora crassa, a model system for epigenetics research. Cold Spring Harb. Perspect. Biol. 5:a017921
8. Arias JF,KoyamaT,KinomotoM,TokunagaK. 2012. Retroelements versusAPOBEC3family members: no great escape from the magnificent seven. Front. Microbiol. 3:275
9. Auton A, Fledel-Alon A, Pfeifer S, Venn O, Segurel L, et al. 2012. A fine-scale chimpanzee genetic map from population sequencing. Science 336:193-98
10. Ayala FJ, Fitch WM. 1997. Genetics and the origin of species: an introduction. PNAS 94:7691-97
11. Bacolla A, Cooper DN, Vasquez KM. 2014. Mechanisms of base substitution mutagenesis in cancer genomes. Genes 5:108-46
12. Bebenek K, Kunkel TA. 1990. Frameshift errors initiated by nucleotide misincorporation. PNAS 87:4946-50
13. Benzer S, Freese E. 1958. Induction of specific mutations with 5-bromouracil. PNAS 44:112-19
14. Berglund J, Pollard KS, WebsterMT. 2009. Hotspots of biased nucleotide substitutions in human genes. PLOS Biol. 7:e26
15. Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, et al. 2014. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat. Commun. 5:2997
16. Buettner VL, Hill KA, Scaringe WA, Sommer SS. 2000. Evidence that proximal multiple mutations in Big Blue transgenic mice are dependent events. Mutat. Res. 452:219-29
17. Burbano HA, Green RE, Maricic T, Lalueza-Fox C, de la Rasilla M, et al. 2012. Analysis of human accelerated DNA regions using archaic hominin genomes. PLOS ONE 7:e32877
18. Burch LH, Yang Y, Sterling JF, Roberts SA, Chao FG, et al. 2011. Damage-induced localized hypermutability. Cell Cycle 10:1073-85
19. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, et al. 2013. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494:366-70
20. Burns MB, Temiz NA, Harris RS. 2013. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 45:977-83
21. Campbell CD, Chong JX, Malig M, Ko A, Dumont BL, et al. 2012. Estimating the human mutation rate using autozygosity in a founder population. Nat. Genet. 44:1277-81
22. Camps M, Herman A, Loh E, Loeb LA. 2007. Genetic constraints on protein evolution. Crit. Rev. Biochem. Mol. Biol. 42:313-26
23. Carmi S, Church GM, Levanon EY. 2011. Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution. Nat. Commun. 2:519
24. Caval V, Suspene R, Shapira M, Vartanian JP,Wain-Hobson S. 2014. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3-UTR enhances chromosomal DNA damage. Nat. Commun. 5:5129
25. Chan K, Resnick MA, Gordenin DA. 2013. The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis. DNA Repair (Amst.) 12:878-89
26. Chan K, Roberts SA, Klimczak LJ, Sterling JF, Saini N, et al. 2015. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet. 47(9):1067-72
27. Chan K, Sterling JF, Roberts SA, Bhagwat AS, Resnick MA, Gordenin DA. 2012. Base damage within single-strand DNA underlies in vivo hypermutability induced by a ubiquitous environmental agent. PLOS Genet. 8:e1003149
28. Chen J, Miller BF, Furano AV. 2014. Repair of naturally occurring mismatches can induce mutations in flanking DNA. eLife 3:e02001
29. Chen Z, Feng J, Buzin CH, Sommer SS. 2008. Epidemiology of doublet/multiplet mutations in lung cancers: evidence that a subset arises by chronocoordinate events. PLOS ONE 3:e3714
30. Chen Z, Feng J, Saldivar JS, Gu D, Bockholt A, Sommer SS. 2008. EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids. Oncogene 27:4336-43
31. Chiu YL,GreeneWC. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-53
32. Coffin JM, Hughes SH, Varmus H. 1997. Retroviruses. Plainview, NY: Cold Spring Harb. Lab. Press
33. Colgin LM, Hackmann AF, Emond MJ, Monnat RJ Jr. 2002. The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage. PNAS 99:1437-42
34. Conticello SG, Thomas CJ, Petersen-Mahrt SK,Neuberger MS. 2005. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22:367-77
35. Costantino L, Sotiriou SK, Rantala JK, Magin S, Mladenov E, et al. 2014. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343:88-91
36. Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, et al. 2014. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26:319-30
37. Deem A, Keszthelyi A, Blackgrove T, Vayl A, Coffey B, et al. 2011. Break-induced replication is highly inaccurate. PLOS Biol. 9:e1000594
38. Degtyareva NP, Heyburn L, Sterling J, Resnick MA, Gordenin DA, Doetsch PW. 2013. Oxidative stress-induced mutagenesis in single-strand DNA occurs primarily at cytosines and is DNA polymerase zeta-dependent only for adenines and guanines. Nucleic Acids Res. 41:8995-9005
39. Dewar JM, Lydall D. 2012. Similarities and differences between "uncapped" telomeres andDNAdoublestrand breaks. Chromosoma 121:117-30
40. Dobzhansky TG. 1937. Genetics and the Origin of Species. New York: Columbia Univ. Press
41. Drake JW. 1999. The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes. Ann. N. Y. Acad. Sci. 870:100-7
42. Drake JW. 2007. Too many mutants with multiple mutations. Crit. Rev. Biochem. Mol. Biol. 42:247-58
43. Dreszer TR, Wall GD, Haussler D, Pollard KS. 2007. Biased clustered substitutions in the human genome: the footprints of male-driven biased gene conversion. Genome Res. 17:1420-30
44. DuretL,Arndt PF. 2008. The impact of recombination on nucleotide substitutions in the human genome. PLOS Genet. 4:e1000071
45. Francioli LC, Polak PP, KorenA,MenelaouA,Chun S, et al. 2015. Genome-wide patterns and properties of de novo mutations in humans. Nat Genet. 47:822-26
46. Friedberg E, Walker G, SiedeW,Wood R, Schultz R, EllenbergerT. 2005.DNARepair andMutagenesis. Washington, DC: ASM Press. 2nd ed
47. Friedberg EC. 2003. DNA damage and repair. Nature 421:436-40
48. Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, et al. 2012. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 14:355-65
49. Gladyshev E, Kleckner N. 2014. Direct recognition of homology between double helices of DNA in Neurospora crassa. Nat. Comm. 5:3509
50. Gomez-Gonzalez B, Aguilera A. 2007. Activation-induced cytidine deaminase action is strongly stimulated by mutations of the THO complex. PNAS 104:8409-14
51. Guthrie VB, Allen J, Camps M, Karchin R. 2011. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories. PLOS Comput. Biol. 7:e1002184
52. Harfe BD, Jinks-Robertson S. 2000. DNA polymerase zeta introduces multiple mutations when bypassing spontaneous DNA damage in Saccharomyces cerevisiae. Mol. Cell 6:1491-99
53. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-9
54. Harris RS, Longerich S, Rosenberg SM. 1994. Recombination in adaptive mutation. Science 264:258-60
55. Harris RS, Petersen-Mahrt SK, Neuberger MS. 2002. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10:1247-53
56. Helleday T, Eshtad S, Nik-Zainal S. 2014. Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15:585-98
57. Hicks WM, Kim M, Haber JE. 2010. Increased mutagenesis and unique mutation signature associated with mitotic gene conversion. Science 329:82-85
58. Hill KA,Wang J, Farwell KD, Scaringe WA, Sommer SS. 2004. Spontaneous multiple mutations show both proximal spacing consistent with chronocoordinate events and alterations with p53-deficiency. Mutat. Res. 554:223-40
59. Kaiser SM,Emerman M. 2006. UracilDNAglycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase APOBEC3G. J. Virol. 80:875-82
60. Kashuba VI, Pavlova TV, Grigorieva EV, Kutsenko A, Yenamandra SP, et al. 2009. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer. PLOS ONE 4:e5231
61. Kasiviswanathan R, Collins TR, CopelandWC. 2012. The interface of transcription and DNA replication in the mitochondria. Biochim. Biophys. Acta 1819:970-78
62. Kaufmann WK. 2007. Initiating the uninitiated: replication of damaged DNA and carcinogenesis. Cell Cycle 6:1460-67
63. Kimura M. 1984. The Neutral Theory of Molecular Evolution. Cambridge, UK: Cambridge Univ. Press
64. Kogenaru M, de Vos MG, Tans SJ. 2009. Revealing evolutionary pathways by fitness landscape reconstruction. Crit. Rev. Biochem. Mol. Biol. 44:169-74
65. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, et al. 1991. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. PNAS 88:7958-62
66. Lada AG, Dhar A, Boissy RJ, Hirano M, Rubel AA, et al. 2012. AID/APOBEC cytosine deaminase induces genome-wide kataegis. Biol. Direct 7:47
67. Lada AG, Stepchenkova EI,Waisertreiger ISR,NoskovVN, Dhar A, et al. 2013. Genome-wide mutation avalanches induced in diploid yeast cells by a base analog or an APOBEC deaminase. PLOS Genet. 9:e1003736
68. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214-18
69. Leman AR, Noguchi E. 2012. Local and global functions of Timeless and Tipin in replication fork protection. Cell Cycle 11:3945-55
70. Lercher MJ, Hurst LD. 2002. Human SNP variability and mutation rate are higher in regions of high recombination. Trends Genet. 18:337-40
71. Levine JG, Schaaper RM, DeMarini DM. 1994. Complex frameshift mutations mediated by plasmid pKM101: mutational mechanisms deduced from 4-aminobiphenyl-induced mutation spectra in Salmonella. Genetics 136:731-46
72. Lindahl T, Barnes DE. 2000. Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 65:127-33
73. Liu M, Schatz DG. 2009. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 30:173-81
74. Long J, Delahanty RJ, Li G, Gao YT, Lu W, et al. 2013. A common deletion in the APOBEC3 genes and breast cancer risk. J. Natl. Cancer Inst. 105:573-79
75. Ma W, Resnick MA,Gordenin DA. 2008. Apn1 and Apn2 endonucleases prevent accumulation of repairassociated DNA breaks in budding yeast as revealed by direct chromosomal analysis. Nucleic Acids Res. 36:1836-46
76. Magni GE, Von Borstel RC. 1962. Different rates of spontaneous mutation during mitosis and meiosis in yeast. Genetics 47:1097-108
77. Malkova A, Haber JE. 2012. Mutations arising during repair of chromosome breaks. Annu. Rev. Genet. 46:455-73
78. Malkova A, Ira G. 2013. Break-induced replication: functions and molecular mechanism. Curr. Opin. Genet. Dev. 23:271-79
79. Mannervik B, Runarsdottir A. 2010. The quest for molecular quasi-species in ligand-activity space and its application to directed enzyme evolution. FEBS Lett. 584:2565-71
80. Matsuda T, Bebenek K, Masutani C, Hanaoka F, Kunkel TA. 2000. Low fidelity DNA synthesis by human DNA polymerase-eta. Nature 404:1011-13
81. Maul RW, Gearhart PJ. 2010. AID and somatic hypermutation. Adv. Immunol. 105:159-91
82. Michaelson JJ, Shi Y, Gujral M, ZhengH,Malhotra D, et al. 2012. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 151:1431-42
83. Miller AS, Balakrishnan L, Buncher NA, Opresko PL, Bambara RA. 2012. Telomere proteins POT1, TRF1 and TRF2 augment long-patch base excision repair in vitro. Cell Cycle 11:998-1007
84. Mimitou EP, Symington LS. 2011. DNA end resection: unraveling the tail. DNA Repair (Amst.) 10:344-48
85. NachmanMW.2001. Single nucleotide polymorphisms and recombination rate in humans. Trends Genet. 17:481-85
86. Nik-Zainal S, Alexandrov LB,Wedge DC, Van Loo P, Greenman CD, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149:979-93
87. Nik-Zainal S, Wedge DC, Alexandrov LB, Petljak M, Butler AP, et al. 2014. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBECdependent mutations in breast cancer. Nat. Genet. 46:487-91
88. Northam MR, Moore EA, Mertz TM, Binz SK, Stith CM, et al. 2014. DNA polymerases and Rev1 mediate error-prone bypass of non-B DNA structures. Nucleic Acids Res. 42:290-306
89. Northam MR, Robinson HA, Kochenova OV, Shcherbakova PV. 2010. Participation of DNA polymerase zeta in replication of undamaged DNA in Saccharomyces cerevisiae. Genetics 184:27-42
90. Ohta T. 1987. Simulating evolution by gene duplication. Genetics 115:207-13
91. Parkhomchuk D, Amstislavskiy V, Soldatov A, Ogryzko V. 2009. Use of high throughput sequencing to observe genome dynamics at a single cell level. PNAS 106:20830-35
92. Pavri R, Nussenzweig MC. 2011. AID targeting in antibody diversity. Adv. Immunol. 110:1-26
93. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, et al. 2008. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26:481-511
94. Pettersen HS, Galashevskaya A, Doseth B, Sousa MM, Sarno A, et al. 2015. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature. DNA Repair (Amst.) 25:60-71
95. Plosky BS, Woodgate R. 2004. Switching from high-fidelity replicases to low-fidelity lesion-bypass polymerases. Curr. Opin. Genet. Dev. 14:113-19
96. Pollard KS, Salama SR, King B, Kern AD, Dreszer T, et al. 2006. Forces shaping the fastest evolving regions in the human genome. PLOS Genet. 2:e168
97. Poon S, McPherson J, Tan P, Teh B, Rozen S. 2014. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med. 6:24
98. Pope-Varsalona H, Liu F-J, Guzik L, Opresko PL. 2014. Polymerase η suppresses telomere defects induced by DNA damaging agents. Nucleic Acids Res. 42:13096-109
99. Povolotskaya IS, Kondrashov FA. 2010. Sequence space and the ongoing expansion of the protein universe. Nature 465:922-26
100. Pratto F, Brick K, Khil P, Smagulova F, Petukhova GV, Camerini-Otero RD. 2014. Recombination initiation maps of individual human genomes. Science 346:6211
101. Qian J, Wang Q, Dose M, Pruett N, Kieffer-KwonKR, et al. 2014. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 159:1524-37
102. Rebhandl S, Huemer M, Gassner FJ, Zaborsky N, Hebenstreit D, et al. 2014. APOBEC3 signature mutations in chronic lymphocytic leukemia. Leukemia 28:1929-32
103. Refsland EW, Harris RS. 2013. The APOBEC3 family of retroelement restriction factors. Curr. Top. Microbiol. Immunol. 371:1-27
104. Rhind N, Gilbert DM. 2013. DNA replication timing. Cold Spring Harb. Perspect. Biol. 5:a010132
105. Richardson SR, Narvaiza I, Planegger RA, Weitzman MD, Moran JV. 2014. APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition. eLife 3:e02008
106. Ripley LS. 1990. Frameshift mutation: determinants of specificity. Annu. Rev. Genet. 24:189-213
107. Roberts SA, Gordenin DA. 2014. Clustered and genome-wide transient mutagenesis in human cancers: hypermutation without permanent mutators or loss of fitness. BioEssays 36:382-93
108. Roberts SA, Gordenin DA. 2014. Clustered mutations in human cancer. eLS doi: 10.1002/ 9780470015902.a0024941
109. Roberts SA, Gordenin DA. 2014. Hypermutation in human cancer genomes: footprints andmechanisms. Nat. Rev. Cancer 14:786-800
110. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, et al. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45:970-76
111. Roberts SA, Sterling J, Thompson C, Harris S, Mav D, et al. 2012. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46:424-35
112. Rochette PJ, Brash DE. 2010. Human telomeres are hypersensitive to UV-induced DNA damage and refractory to repair. PLOS Genet. 6:e1000926
113. Rogozin IB, Pavlov YI. 2003. Theoretical analysis ofmutation hotspots and theirDNA sequence context specificity. Mutat. Res. Rev. Mutat. 544:65-85
114. Rogozin IB, Pavlov YI, Bebenek K, Matsuda T, Kunkel TA. 2001. Somatic mutation hotspots correlate with DNA polymerase ηerror spectrum. Nat. Immunol. 2:530-36
115. Saini N, Ramakrishnan S, Elango R, Ayyar S, Zhang Y, et al. 2013. Migrating bubble during breakinduced replication drives conservative DNA synthesis. Nature 502:389-92
116. Sakofsky CJ, Roberts SA, Malc E, Mieczkowski PA, Resnick MA, et al. 2014. Break-induced replication is a source of mutation clusters underlying kataegis. Cell Rep. 7:1640-48
117. Sale JE. 2013. Translesion DNA synthesis and mutagenesis in eukaryotes. Cold Spring Harb. Perspect. Biol. 5:a012708
118. Schumacher AJ, Hache G, Macduff DA, BrownWL, Harris RS. 2008. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82:2652-60
119. Schumacher AJ, Nissley DV, Harris RS. 2005. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. PNAS 102:9854-59
120. Shcherbakova PV, Fijalkowska IJ. 2006. Translesion synthesis DNA polymerases and control of genome stability. Front. Biosci. 11:2496-517
121. Sima J, Gilbert DM. 2014. Complex correlations: replication timing and mutational landscapes during cancer and genome evolution. Curr. Opin. Genet. Dev. 25:93-100
122. Smith JM. 1970. Natural selection and the concept of a protein space. Nature 225:563-64
123. Spencer CC, Deloukas P, Hunt S, Mullikin J, Myers S, et al. 2006. The influence of recombination on human genetic diversity. PLOS Genet. 2:e148
124. Stamatoyannopoulos JA, Adzhubei I,Thurman RE,Kryukov GV,Mirkin SM, Sunyaev SR. 2009.Human mutation rate associated with DNA replication timing. Nat. Genet. 41:393-95
125. Steele EJ. 2009. Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs. Mol. Immunol. 46:305-20
126. Stone JE, Lujan SA, Kunkel TA. 2012. DNA polymerase zeta generates clustered mutations during bypass of endogenous DNA lesions in Saccharomyces cerevisiae. Environ. Mol. Mutagen. 53:777-86
127. Strathern JN, Shafer BK, McGill CB. 1995. DNA synthesis errors associated with double-strand-break repair. Genetics 140:965-72
128. Stumpf JD, CopelandWC. 2014. MMS exposure promotes increased MtDNA mutagenesis in the presence of replication-defective disease-associated DNA polymerase γvariants. PLOS Genet. 10:e1004748
129. Sunagar K, Fry BG, Jackson TN, Casewell NR, Undheim EA, et al. 2013. Molecular evolution of vertebrate neurotrophins: co-option of the highly conserved nerve growth factor gene into the advanced snake venom arsenal. PLOS ONE 8:e81827
130. Tang H, Kuhen KL, Wong-Staal F. 1999. Lentivirus replication and regulation. Annu. Rev. Genet. 33:133-70
131. Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, et al. 2013. DNA deaminases induce breakassociated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2:e00534
132. Taylor BJ, Wu YL, Rada C. 2014. Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes. eLife 3:e03553
133. Teng G, Papavasiliou FN. 2007. Immunoglobulin somatic hypermutation. Annu. Rev. Genet. 41:107-20
134. Timofeeff-Ressovsky N, Zimmer K, Delbr uck M. 1935. The nature of genetic mutations and structure of the gene. Nachr. Biol. Ges. Wiss. Gott. 1:189-245
135. Wang J, Gonzalez KD, Scaringe WA, Tsai K, Liu N, et al. 2007. Evidence for mutation showers. PNAS 104:8403-8
136. Weinreich DM,Watson RA, Chao L. 2005. Perspective: sign epistasis and genetic constraint on evolutionary trajectories. Evolution 59:1165-74
137. WilburnDB, Bowen KE, Doty KA, Arumugam S, Lane AN, et al. 2014. Structural insights into the evolution of a sexy protein: novel topology and restricted backbone flexibility in a hypervariable pheromone from the red-legged salamander, Plethodon shermani. PLOS ONE 9:e96975
138. Willis NA, Chandramouly G, Huang B, Kwok A, Follonier C, et al. 2014. BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks. Nature 510:556-59
139. Wright S. 1932. The roles of mutation, inbreeding, crossbreading and selection in evolution. Proc. Sixth Int. Congr. Genet. 1:356-66
140. Xuan D, Li G, Cai Q, Deming-Halverson S, Shrubsole MJ, et al. 2013. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 34:2240-43
141. Yang B, Chen K, Zhang C, Huang S, Zhang H. 2007. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA. J. Biol. Chem. 282:11667-75
142. Yang Y, Gordenin DA, Resnick MA. 2010. A single-strand specific lesion drives MMS-induced hypermutability at a double-strand break in yeast. DNA Repair (Amst.) 9:914-21
143. Yang Y, Sterling J, Storici F, Resnick MA, Gordenin DA. 2008. Hypermutability of damaged singlestrand DNA formed at double-strand breaks and uncapped telomeres in yeast Saccharomyces cerevisiae. PLOS Genet. 4:e1000264